Cargando…

Increased mitochondrial calcium levels associated with neuronal death in a mouse model of Alzheimer’s disease

Mitochondria contribute to shape intraneuronal Ca(2+) signals. Excessive Ca(2+) taken up by mitochondria could lead to cell death. Amyloid beta (Aβ) causes cytosolic Ca(2+) overload, but the effects of Aβ on mitochondrial Ca(2+) levels in Alzheimer’s disease (AD) remain unclear. Using a ratiometric...

Descripción completa

Detalles Bibliográficos
Autores principales: Calvo-Rodriguez, Maria, Hou, Steven S., Snyder, Austin C., Kharitonova, Elizabeth K., Russ, Alyssa N., Das, Sudeshna, Fan, Zhanyun, Muzikansky, Alona, Garcia-Alloza, Monica, Serrano-Pozo, Alberto, Hudry, Eloise, Bacskai, Brian J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7195480/
https://www.ncbi.nlm.nih.gov/pubmed/32358564
http://dx.doi.org/10.1038/s41467-020-16074-2
Descripción
Sumario:Mitochondria contribute to shape intraneuronal Ca(2+) signals. Excessive Ca(2+) taken up by mitochondria could lead to cell death. Amyloid beta (Aβ) causes cytosolic Ca(2+) overload, but the effects of Aβ on mitochondrial Ca(2+) levels in Alzheimer’s disease (AD) remain unclear. Using a ratiometric Ca(2+) indicator targeted to neuronal mitochondria and intravital multiphoton microscopy, we find increased mitochondrial Ca(2+) levels associated with plaque deposition and neuronal death in a transgenic mouse model of cerebral β-amyloidosis. Naturally secreted soluble Aβ applied onto the healthy brain increases Ca(2+) concentration in mitochondria, which is prevented by blockage of the mitochondrial calcium uniporter. RNA-sequencing from post-mortem AD human brains shows downregulation in the expression of mitochondrial influx Ca(2+) transporter genes, but upregulation in the genes related to mitochondrial Ca(2+) efflux pathways, suggesting a counteracting effect to avoid Ca(2+) overload. We propose lowering neuronal mitochondrial Ca(2+) by inhibiting the mitochondrial Ca(2+) uniporter as a novel potential therapeutic target against AD.